Strategic partnership AION Biosystems recently partnered with Olio to integrate TempShield into post-discharge coordination and Safe Return workflows, signaling a need for expanded hospital-to-home health technology integrations and care transition solutions in Indiana. This presents a sales opportunity to offer scalable monitoring and data sharing platforms that support early infection detection during care transitions.

Early detection focus The company emphasizes early detection of infections to improve patient outcomes, indicating a buyer persona that prioritizes preventative surveillance, wearable monitoring, and real-time data analytics. Upsell opportunities exist for additional sensors, analytics dashboards, and integration with electronic health records.

Tech stack fit With a client-facing footprint likely leveraging Salesforce, SAP, NetSuite, WordPress, and Microsoft 365, AION Biosystems may value interoperable solutions and ecosystem integrations. Position complementary enterprise tooling, CRM/ERP enhancements, and secure hosting options that align with their current stack.

Growth and scale Revenue range ($10M-$25M) and a small-to-mid-size employee base (11-50) suggest a growth phase with appetite for scalable partnerships, targeted deployments, and pilot programs that can evolve into broader rollouts across care networks and potentially additional regions beyond Indiana.

Funding signal Moderate funding of $3.6M alongside commercialization of FDA-cleared wearable technology indicates willingness to invest in technology-enabled healthcare solutions. This creates opportunities for co-development, sponsorship of field trials, and utilization of funding-friendly procurement channels.